Are NYHA progression and HF hospitalization markers of clinical worsening related to death, HTX, and VAD implantation in ACHD-HF patients?
NYHA progression and HF hospitalization are identified as potential markers of clinical worsening for severe outcomes (death, HTX, VAD) in adult congenital heart disease patients with heart failure.
This study characterizes current ACHD-HF therapy and identifies NYHA progression and HF hospitalization as potential markers of clinical worsening as they relate to death, HTX, and VAD implantation.
Bourgeois et al. (Wed,) studied this question.